FDA Forms Bisphosphonate Advisory Panel - Osteoporosis
Links shared publicly online about this topic.
- 122total visits
FDA Forms Bisphosphonate Advisory Panel - Osteoporosis
View full resource at healthcentral.com
Tags: Osteoporosis, Osteoporosis Medication, Drug, FDA, Fosamax, Boniva
Most Recently Shared on July 25, 2011 at 3:36 am By:
FDA Forms Bisphosphonate Advisory Panel - Osteoporosis: http://t.co/xQCVkHg via @AddThis @phflores @healthcentral #osteoporosis
Pancreatic cancer: FDA panel recommends use of two drugs for rare form of pancreatic cancer - South Florida Sun-Sentinel.com
sun-sentinel.com — “FDA advisory panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects, increasing the likelihood that the Food and Drug Administration will approve their use against pancreatic neuroendocrine tumors.” View full resource at sun-sentinel.com
Most Recently Shared on April 14, 2011 at 3:21 pm By:
LegalMedsDirect Health Business
FDA panel recommends two drugs for rare form of pancreatic cancer http://dld.bz/W6hT
Pancreatic cancer: FDA panel recommends use of two drugs for rare form of pancreatic cancer - latimes.com
latimes.com — “FDA advisory panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects, increasing the likelihood that the Food and Drug Administration will approve their use against pancreatic neuroendocrine tumors.” View full resource at latimes.com
Most Recently Shared on April 13, 2011 at 4:30 pm By:
FDA panel recommends two drugs for rare form of pancreatic cancer http://lat.ms/hDorf2
Pancreatic cancer: FDA panel recommends use of two drugs for rare form of pancreatic cancer - latimes.com
latimes.com — “FDA advisory panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects, increasing the likelihood that the Food and Drug Administration will approve their use against pancreatic neuroendocrine tumors.” View full resource at latimes.com
Most Recently Shared on April 13, 2011 at 10:40 am By:
Drugs and Devices OW OW Health
FDA panel recommends two drugs for rare form of pancreatic cancer: The panel finds that the benefits of Novartis... http://lat.ms/iapooG
Pancreatic cancer: FDA panel recommends use of two drugs for rare form of pancreatic cancer - latimes.com
latimes.com — “FDA advisory panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects, increasing the likelihood that the Food and Drug Administration will approve their use against pancreatic neuroendocrine tumors.” View full resource at latimes.com
Most Recently Shared on April 13, 2011 at 4:39 am By:
Drugs and Devices OW OW Health
FDA panel recommends two drugs for rare form of pancreatic cancer: The panel finds that the benefits of Novartis... http://lat.ms/gi4WEC
FDA panel urges OK of first oral MS drug – The Chart - CNN.com Blogs
thechart.blogs.cnn.com — “By Georgiann Caruso CNN Medical Associate Producer An FDA advisory committee on Thursday recommended approval of the first oral treatment for relapsing forms of multiple sclerosis.” View full resource at thechart.blogs.cnn.com
Most Recently Shared on June 14, 2010 at 4:45 pm By:
Christian Caicedo Family Medicine Doctor, Physician, and Doctor
FDA Panel urges OK of first oral MS drug http://tinyurl.com/328mdjy
Medical News: FDA Advisory Panel to Discuss MS Drug - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- Fingolimod (Gilenia), the first oral drug aimed at treating the relapsing-remitting form of multiple sclerosis, will be the subject of an FDA advisory committee hearing here tomo” View full resource at medpagetoday.com
Most Recently Shared on June 10, 2010 at 6:20 pm By:
FDA Advisory Panel to Discuss MS Drug: SILVER SPRING, Md. (MedPage Today) -- Fingolimod (Gilenia), the first oral ... http://bit.ly/af0pd2
Medical News: FDA Forms New Tobacco Products Panel - in Pulmonology, Smoking & Tobacco from MedPage Today
medpagetoday.com — “WASHINGTON -- The Food and Drug Administration named members to its new Tobacco Products Scientific Advisory Committee, which will have its first meeting at the end of the month to discuss menthol in” View full resource at medpagetoday.com
Most Recently Shared on March 2, 2010 at 4:07 pm By:
FDA Forms New Tobacco Products Panel WASHINGTON (MedPage Today) -- The Food and Drug Administration named members to .. http://bit.ly/dcV8Wt
Advertisement
